149 related articles for article (PubMed ID: 10343609)
1. Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy.
Wang Q; Stamp GW; Powell S; Abel P; Laniado M; Mahony C; Lalani EN; Waxman J
J Clin Pathol; 1999 Jan; 52(1):29-34. PubMed ID: 10343609
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
[TBL] [Abstract][Full Text] [Related]
3. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
4. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8.
Dorkin TJ; Robinson MC; Marsh C; Neal DE; Leung HY
J Pathol; 1999 Dec; 189(4):564-9. PubMed ID: 10629559
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid switches differential expression of FGF8 isoforms in LNCaP cells.
Brondani V; Hamy F
Biochem Biophys Res Commun; 2000 May; 272(1):98-103. PubMed ID: 10872810
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS
Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296
[TBL] [Abstract][Full Text] [Related]
8. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
9. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
Straub B; Müller M; Krause H; Schrader M; Miller K
Urology; 2003 Jul; 62(1):172-6. PubMed ID: 12837461
[TBL] [Abstract][Full Text] [Related]
12. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
Bouras T; Frauman AG
J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
[TBL] [Abstract][Full Text] [Related]
13. FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease.
Dorkin TJ; Robinson MC; Marsh C; Bjartell A; Neal DE; Leung HY
Oncogene; 1999 Apr; 18(17):2755-61. PubMed ID: 10348350
[TBL] [Abstract][Full Text] [Related]
14. FGF8 isoform b expression in human prostate cancer.
Gnanapragasam VJ; Robinson MC; Marsh C; Robson CN; Hamdy FC; Leung HY
Br J Cancer; 2003 May; 88(9):1432-8. PubMed ID: 12778074
[TBL] [Abstract][Full Text] [Related]
15. CaT1 expression correlates with tumor grade in prostate cancer.
Peng JB; Zhuang L; Berger UV; Adam RM; Williams BJ; Brown EM; Hediger MA; Freeman MR
Biochem Biophys Res Commun; 2001 Apr; 282(3):729-34. PubMed ID: 11401523
[TBL] [Abstract][Full Text] [Related]
16. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
[TBL] [Abstract][Full Text] [Related]
17. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 8 expression in breast carcinoma: associations with androgen receptor and prostate-specific antigen expressions.
Tanaka A; Kamiakito T; Takayashiki N; Sakurai S; Saito K
Virchows Arch; 2002 Oct; 441(4):380-4. PubMed ID: 12404063
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
Glynne-Jones E; Goddard L; Harper ME
Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
[TBL] [Abstract][Full Text] [Related]
20. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.
Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N
Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
